WuXi Biologics (Cayman) Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| 1FW1.F | 3759.HK | 688202.SS | 2315.HK | 688062.SS | 002007.SZ | |
|---|---|---|---|---|---|---|
| Market cap | 22.64B | 55.85B | 10.63B | 19.07B | 10.13B | 22.75B |
| P/E (TTM) | 37.9 | 27.4 | — | 45.2 | — | 38.9 |
| Forward P/E | — | 17.2 | 35.8 | 28.0 | -21.6 | 11.1 |
| Price/book | 3.5 | 2.8 | 5.2 | 6.6 | 14.1 | 2.1 |
| Dividend yield | — | 0.78% | — | — | — | 7.95% |
| 1-year change | +44.16% | +19.72% | +15.42% | +48.24% | −51.34% | −22.82% |
| Today | −0.90% | +3.47% | +2.00% | +2.09% | +5.29% | −0.95% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All 1FW1.F news ›WuXi Biologics (Cayman) Inc.: Relative Strength Chart - Stock Hong Kong S.E.
Compare WuXi Biologics (Cayman) Inc. with the company of your choice via a Relative Strength chart. Real-time 2269 price, Hong Kong S.E. stock exchange Relative Strength Chart WuXi Biologics (Cayman) Inc. Biotechnology & Medical Research…
Jefferies Adjusts WuXi Biologics (Cayman)'s Price Target to HK$60 From HK$50, Keeps at Buy
WuXi Biologics has an average rating of overweight and mean price target of HK$50.15, according to analysts polled by FactSet. ... WuXi Biologics (Cayman) Inc. Biotechnology & Medical Research Jefferies Adjusts WuXi Biologics (Cayman)'s…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com4
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 4 articles, not a forecast.